Top Biotechnology companies in Netherlands by Capital Expenditure To Sales for September 19, 2024

This ranking features the top 1 Biotechnology companies in Netherlands, based on their Capital Expenditure To Sales for September 19, 2024.

Netherlands
Biotechnology
1 companies - Average Capital Expenditure To Sales: 27.63% 
Data sourced from iex and EODHD
Rank by
Download Data
#
Name
Capital Expenditure To Sales
Reported Date
Stock Price
Price (30 days)
Change
 Country
10 25 50
Frequently Asked Questions
  • Which Biotechnology company in Netherlands has the highest Capital Expenditure To Sales ?

    The Biotechnology company in Netherlands with the highest Capital Expenditure To Sales is Uniqure NV (NASDAQ: QURE) at 27.63%.

  • Which Biotechnology company in Netherlands has the lowest Capital Expenditure To Sales ?

    The Biotechnology company in Netherlands with the lowest Capital Expenditure To Sales is Uniqure NV (NASDAQ: QURE) at 27.63%.

  • What are the top 10 Biotechnology companies in Netherlands by Capital Expenditure To Sales ?

    The top 10 Biotechnology companies in Netherlands by Capital Expenditure To Sales are and Uniqure NV.

  • What are the bottom 10 Biotechnology companies in Netherlands by Capital Expenditure To Sales ?

    The bottom 10 Biotechnology companies in Netherlands by Capital Expenditure To Sales are and Uniqure NV.